Currently, gastrointestinal dysfunctions in Parkinson’s disease (PD) are well-recognized problems and are known to be an initial symptom in the pathological process that eventually results in PD. Gastrointestinal symptoms may result from the involvement of either the central or enteric nervous systems, or these symptoms may be side effects of antiparkinsonian medications. Weight loss, excessive salivation, dysphagia, nausea/gastroparesis, constipation, and defecation dysfunction all may occur. Increased identification and early detection of these symptoms can result in a significant improvement in the quality of life for PD patients.
Citations
Citations to this article as recorded by
Short-chain fatty acids mediate enteric and central nervous system homeostasis in Parkinson’s disease: Innovative therapies and their translation Shimin Pang, Zhili Ren, Hui Ding, Piu Chan Neural Regeneration Research.2026; 21(3): 938. CrossRef
Consensus expert recommendations for management of dysphagia during hospital admission in Parkinson's disease Delaram Safarpour, Annie Brooks, Adrianne Smiley, David A Katzka, David R Shprecher, James G Greene, Rajesh Pahwa, Michelle S Troche, Zoe Kriegel, Emily P Peron, Amanda Bryant, Alfonso Fasano, Mary Ochoa, Adolfo Ramirez-Zamora, Marty Acevedo, Gina Mari Bl Journal of Parkinson’s Disease.2026; 16(1): 16. CrossRef
DA-9701 for Gastrointestinal Symptoms in Postural Orthostatic Tachycardia Syndrome: A Randomized Pilot Study Hee-Jae Jung, Dayoung Seo, Hyunjin Kim, Young-Min Lim, Ji-Sung Lee, Eun-Jae Lee Journal of Neurogastroenterology and Motility.2026; 32(2): 228. CrossRef
Gut–Brain Signaling in Parkinson’s Disease: A Narrative Review Karolina Ratajczyk, Emilia Kaczorowska, Karolina Wyka, Aleksandra Tarasiuk-Zawadzka, Jakub Fichna, Agata Gajos International Journal of Molecular Sciences.2026; 27(8): 3531. CrossRef
The taste of Parkinson's: How food choices reflect nutritional health Onanong Phokaewvarangkul, Narumol Sukmueng, Panthitra Kuwattanasuchati, Kanyawat Sanyawut, Naruemon Rattanapitak, Roongroj Bhidayasiri Journal of Parkinson’s Disease.2026;[Epub] CrossRef
Neurotoxic phospholipase A2: A proposed cause of equine grass sickness and other animal dysautonomias (multiple system neuropathies) Bruce McGorum, R. Scott Pirie, Luca Bano, Tracey Davey, John Harris, Cesare Montecucco Equine Veterinary Journal.2025; 57(1): 11. CrossRef
Efficacy and safety of GLP-1 agonists in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials Mark Messak, Ahmed Abdelmageed, Abdelrahman A. Senbel, Youssef A. Khattab, Youssef Mandour, Omar Shaker, Ahmed Hamed Rehan, Samir Oransa, Mohamed Nasr, Abdullah Emad Shabeeb, Ziyad Rezq, Fares Hossam, Moaz Elsayed Abouelmagd Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(8): 9721. CrossRef
Vital nutrition: enhancing health in advanced Parkinson’s disease with device-aided therapies Onanong Phokaewvarangkul, Ioanna Markaki, Harmen R. Moes, Igor Petrovic, Anette Schrag, Roongroj Bhidayasiri Journal of Neural Transmission.2025; 132(11): 1685. CrossRef
Gut neuropeptide involvement in Parkinson’s disease Hayley N. Templeton, Stuart A. Tobet, Luke A. Schwerdtfeger American Journal of Physiology-Gastrointestinal and Liver Physiology.2025; 328(6): G716. CrossRef
Assessment of body composition, sarcopenia and protein intake in mild to moderate Parkinson’s disease Danielle Pessoa Lima, Pauliana Alencar Monteiro, João Rafael Gomes de Luna, Antonio Brazil Viana-Júnior, Lucas Tadeu Rocha Santos, Samuel Brito de Almeida, Rayanne Rego Ferreira Saldanha, Madeleine Sales de Alencar, Fábia Karine de Moura Lopes, Átila Pere Frontiers in Nutrition.2025;[Epub] CrossRef
The ketogenic diet in Parkinson’s disease: a potential therapeutic strategy Barbara Pokora, Kacper Pokora, Agata Binienda, Jakub Fichna Pharmacological Reports.2025; 77(6): 1491. CrossRef
Investigation of the intervention mechanism of total flavonoids of Polygonum divaricatum L. on MPTP-induced Parkinson's disease mice based on the interaction between metabolomics and gut microbial diversity Xiaoran Chen, Ru Liang, Caiyun Tian, Lingxuan Fan, Hongli Zhang, Bowen Gao, Chaohui Duan Fitoterapia.2025; 187: 106947. CrossRef
Sulfate reducing bacteria induce α-synuclein in intestinal and neuronal cells and tissues and inhibit tyrosine hydroxylase in neuronal cells Sudha B. Singh, Arianne J. Capacio, Cody A. Braun, Amanda Carroll-Portillo, Sephira Ryman, Henry C. Lin Frontiers in Neuroscience.2025;[Epub] CrossRef
Regulation of Pain Perception by Microbiota in Parkinson Disease Zulmary Manjarres, Margarita Calvo, Rodrigo Pacheco Pharmacological Reviews.2024; 76(1): 7. CrossRef
Emerging wearable technologies for multisystem monitoring and treatment of Parkinson’s disease: a narrative review Yasmine M. Kehnemouyi, Todd P. Coleman, Peter A. Tass Frontiers in Network Physiology.2024;[Epub] CrossRef
ICAM-1 may promote the loss of dopaminergic neurons by regulating inflammation in MPTP-induced Parkinson’s disease mouse models Fen Zhang, Lixin Pan, Changlin Lian, Zhifeng Xu, Hongda Chen, Wenjie Lai, Xiaojue Liang, Qiyuan Liu, Haomin Wu, Yukai Wang, Pande Zhang, Guohua Zhang, Zhen Liu Brain Research Bulletin.2024; 214: 110989. CrossRef
Fecal microbiota from patients with Parkinson's disease intensifies inflammation and neurodegeneration in A53T mice Huijia Yang, Yaping Shao, Yiying Hu, Jin Qian, Panpan Wang, Lulu Tian, Yang Ni, Song Li, Murad Al‐Nusaif, Cong Liu, Weidong Le CNS Neuroscience & Therapeutics.2024;[Epub] CrossRef
N-acetyl-L-leucine protects MPTP-treated Parkinson’s disease mouse models by suppressing Desulfobacterota via the gut-brain axis Zhifeng Xu, Changlin Lian, Lixin Pan, Wenjie Lai, Fen Zhang, Lingmei Peng, Sijie Zhou, Guanghua Zhao, Xuezhu Yang, Guohua Zhang, Zefeng Tan, Yukai Wang Brain Research Bulletin.2023; 202: 110729. CrossRef
Anesthetic Considerations for Cataract Surgery in Patients with Parkinson’s Disease: A Narrative Review Alyssa Chiew, David Mathew, Chandra M. Kumar, Edwin Seet, Farnad Imani, Seyed-Hossein Khademi Anesthesiology and Pain Medicine.2023;[Epub] CrossRef
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our
Mental Health Nirav Yogesh Bhatia, Manjiri Prabhakar Jalgaonkar, Anuja Balu Hargude, Atul P. Sherje, Manisha Jignesh Oza, Gaurav Mahesh Doshi CNS & Neurological Disorders - Drug Targets.2023; 22(7): 1008. CrossRef
A look back at the prodromal findings in Parkinson’s disease Seyed-Amirabbas Ahadiat, Zeinab Hosseinian Bulletin of the National Research Centre.2023;[Epub] CrossRef
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies Xuxiang Zhang, Beisha Tang, Jifeng Guo Translational Neurodegeneration.2023;[Epub] CrossRef
Association between malnutrition and motor/non-motor symptoms in elderly with Parkinson disease Heewon Bae, Sang-Won Ha Journal of Geriatric Neurology.2023; 2(2): 58. CrossRef
Gastrointestinal Sensory Neuropathy and Dysmotility in Fabry Disease: Presentations and Effect on Patient's Quality of Life Nir Bar, Amel Karaa, Katheryn Kiser, Braden Kuo, Claire Zar-Kessler Clinical and Translational Gastroenterology.2023; 14(12): e00633. CrossRef
Nutritional aspects in Parkinson’s disease Paulina Gątarek, Joanna Kałużna-Czaplińska Critical Reviews in Food Science and Nutrition.2022; 62(23): 6467. CrossRef
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease Margherita Alfonsetti, Vanessa Castelli, Michele d’Angelo Nutrients.2022; 14(2): 380. CrossRef
Factors Contributing to Malnutrition in Parkinson's Disease Patients With Freezing of Gait Li-Li Zhang, Liang Zhang, Jingde Dong, Ying Zhao, Xiao-Ping Wang Frontiers in Neurology.2022;[Epub] CrossRef
Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights Tong Guo, Li Chen European Journal of Inflammation.2022;[Epub] CrossRef
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease Sujith Pavan, Arvind N. Prabhu, Sankar Prasad Gorthi, Bhabatosh Das, Ankur Mutreja, Vignesh Shetty, Thandavarayan Ramamurthy, Mamatha Ballal Folia Microbiologica.2022; 67(5): 693. CrossRef
Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders Parvin Oroojzadeh, Saber Yari Bostanabad, Hajie Lotfi Journal of Molecular Neuroscience.2022; 72(9): 1952. CrossRef
Cardiac sympathetic denervation could be associated with dysphagia in Parkinson's disease Jinyoung Youn, George Umemoto, Eungseok Oh, Jinse Park, Wooyoung Jang, Yoon-Sang Oh, Hee-Tae Kim, Jin Whan Cho, Shinsuke Fujioka, Yoshio Tsuboi Frontiers in Neurology.2022;[Epub] CrossRef
The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders Yasir Bashir, Asad U. Khan Frontiers in Neuroscience.2022;[Epub] CrossRef
Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases Zhong Chen, Javeria Maqbool, Faiqa Sajid, Ghulam Hussain, Tao Sun Microbial Pathogenesis.2021; 150: 104675. CrossRef
Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis Zhe Zhao, Fangyuan Li, Jingwen Ning, Ran Peng, Junmei Shang, Hui Liu, Meiyu Shang, Xiu-Qi Bao, Dan Zhang Acta Pharmaceutica Sinica B.2021;[Epub] CrossRef
Murine Esophagus Expresses Glial-Derived Central Nervous System Antigens Christopher Kapitza, Rittika Chunder, Anja Scheller, Katherine S. Given, Wendy B. Macklin, Michael Enders, Stefanie Kuerten, Winfried L. Neuhuber, Jürgen Wörl International Journal of Molecular Sciences.2021; 22(6): 3233. CrossRef
Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson’s Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein Zhe Zhong, Weijie Chen, Huan Gao, Ningning Che, Min Xu, Lanqing Yang, Yingfang Zhang, Min Ye Neurochemical Research.2021; 46(11): 3050. CrossRef
ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease Shanti Diwakarla, Rachel M. McQuade, Remy Constable, Olivia Artaiz, Enie Lei, Kevin J. Barnham, Paul A. Adlard, Robert A. Cherny, Madeleine R. Di Natale, Hongyi Wu, Xin-yi Chai, Victoria A. Lawson, David I. Finkelstein, John B. Furness Journal of Parkinson's Disease.2021; 11(4): 1821. CrossRef
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, Anna Serefko, Marcin Włodarczyk, Anna Zielińska, Ewa Poleszak, Jakub Fichna, Piotr Wlaź Pharmacological Research.2021; 172: 105840. CrossRef
Transplantation of gut microbiota derived from Alzheimer’s disease mouse model impairs memory function and neurogenesis in C57BL/6 mice Namkwon Kim, Seung Ho Jeon, In Gyoung Ju, Min Sung Gee, Jimin Do, Myung Sook Oh, Jong Kil Lee Brain, Behavior, and Immunity.2021; 98: 357. CrossRef
Exploring the Role of Orexinergic Neurons in Parkinson’s Disease Sachin Kumar, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harassi, Mohammed M. Abdel-Daim, Simona Bungau Neurotoxicity Research.2021; 39(6): 2141. CrossRef
Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis Zhe Zhao, Jingwen Ning, Xiu-qi Bao, Meiyu Shang, Jingwei Ma, Gen Li, Dan Zhang Microbiome.2021;[Epub] CrossRef
Chronic isolation stress is associated with increased colonic and motor symptoms in the A53T mouse model of Parkinson’s disease Shanti Diwakarla, David I. Finkelstein, Remy Constable, Olivia Artaiz, Madeleine Di Natale, Rachel M. McQuade, Enie Lei, Xin‐yi Chai, Mitchell T. Ringuet, Linda J. Fothergill, Victoria A. Lawson, Laura J. Ellett, Joel P. Berger, John B. Furness Neurogastroenterology & Motility.2020;[Epub] CrossRef
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Pa European Journal of Pharmaceutical Sciences.2020; 147: 105280. CrossRef
Estado nutricional de idosos com doença de Parkinson e seus fatores associados: uma revisão integrativa Nívola Beatriz Mendonça de Arruda, Suelane Renata de Andrade Silva, Nadja Maria Jorge Asano, Maria das Graças Wanderley de Sales Coriolano Revista Brasileira de Geriatria e Gerontologia.2020;[Epub] CrossRef
Probiotics for Parkinson’s Disease Parisa Gazerani International Journal of Molecular Sciences.2019; 20(17): 4121. CrossRef
Hyper-serotonergic state determines onset and progression of idiopathic Parkinson’s disease Eliseu da Cruz Moreira-Junior Medical Hypotheses.2019; 133: 109399. CrossRef
Constipation Increases Disability and Decreases Dopamine Levels in the Nigrostriatal System through Gastric Inflammatory Factors in Parkinson’s Disease Yongtao Zhou, Yusheng Su, Weihua Xu, Wei Wang, Shukun Yao Current Neurovascular Research.2019; 16(3): 241. CrossRef
α-Synuclein Regulates Development and Function of Cholinergic Enteric Neurons in the Mouse Colon M. Swaminathan, C. Fung, D.I. Finkelstein, J.C. Bornstein, J.P.P. Foong Neuroscience.2019; 423: 76. CrossRef
Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway Meng-Fei Sun, Ying-Li Zhu, Zhi-Lan Zhou, Xue-Bing Jia, Yi-Da Xu, Qin Yang, Chun Cui, Yan-Qin Shen Brain, Behavior, and Immunity.2018; 70: 48. CrossRef
Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease Meng-Fei Sun, Yan-Qin Shen Ageing Research Reviews.2018; 45: 53. CrossRef
Increased risk of all‐cause mortality associated with domperidone use in Parkinson's patients: a population‐based cohort study in the UK Marina Simeonova, Frank de Vries, Sander Pouwels, Johanna H. M. Driessen, Hubert G.M. Leufkens, Suzanne M. Cadarette, Andrea M. Burden British Journal of Clinical Pharmacology.2018; 84(11): 2551. CrossRef
Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial Tsuyoshi Miyaoka, Misako Kanayama, Rei Wake, Sadayuki Hashioka, Maiko Hayashida, Michiharu Nagahama, Shihoh Okazaki, Satoko Yamashita, Shoko Miura, Hiroyuki Miki, Hiroyuki Matsuda, Masahiro Koike, Muneto Izuhara, Tomoko Araki, Keiko Tsuchie, Ilhamuddin Ab Clinical Neuropharmacology.2018; 41(5): 151. CrossRef
Role of Microbiota in Neurodegenerative Diseases C. V. Sobol Russian Journal of Developmental Biology.2018; 49(6): 297. CrossRef
α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang Neurological Sciences.2017; 38(1): 171. CrossRef
Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo Journal of Movement Disorders.2017; 10(1): 29. CrossRef
Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective Sun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, Arturo Benitez, Babak Boroojerdi, Tanja Heidbrede, Allison Little, Han Joon Kim Expert Review of Neurotherapeutics.2017; 17(7): 737. CrossRef
Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota Jing Sun, Fangyan Wang, Zongxin Ling, Xichong Yu, Wenqian Chen, Haixiao Li, Jiangtao Jin, Mengqi Pang, Huiqing Zhang, Junjie Yu, Jiaming Liu Brain Research.2016; 1642: 180. CrossRef
Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study Chava Peretz, Ron Gurel, Violet Rozani, Tanya Gurevich, Baruch El-Ad, Judith Tsamir, Nir Giladi Parkinsonism & Related Disorders.2016;[Epub] CrossRef
An Incidental Finding of a Radiopaque Pill following Cervical Spinal Surgery in a Parkinson's Disease Patient Bon Sub Gu, Soo-Jung Choi, Byoungwoo Yoo, Koon Hee Han, Jong Kyu Park, Young-Seok Lee, Jin Hoon Park Korean Journal of Spine.2015; 12(3): 153. CrossRef
Objective: Although gastrointestinal dysfunctions occur in the majority of patients with Parkinson’s disease (PD), they are often unrecognized because many patients remain relatively asymptomatic in the early stage. We investigated the frequency of gastrointestinal symptoms in patients with PD using newly developed gastrointestinal symptom questionnaires. Methods: Early PD patients with a symptom duration not exceeding 3 years were included in this study. All PD patients were evaluated using a questionnaire, which consisted of three relevant domains: oropharyngoesophageal (10 items); gastric (3 items); and intestinal-anorectal (7 items). The frequency of symptoms was calculated as a proportion with an item score ≥ 2. Results: Of the 54 patients enrolled, 48 patients (88.9%) responded that bowel symptoms developed before the onset of Parkinsonian motor symptoms, and four patients reported that the onset of two types of symptoms (i.e., bowel and neurological) occurred approximately simultaneously, with only months between them. The frequencies of gastrointestinal symptoms are as follows: speech disturbance (40.7%), drooling (24.1%), sense of getting stuck (31.5%), choking (27.8%), globus pharyngis (16.7%), repetitive deglutition (29.6%), pain during swallowing (5.6%), food regurgitation (3.7%), acid reflux (7.4%), nausea/ vomiting (11.1%), early satiety (16.7%), postprandial fullness (14.8%), epigastric soreness (9.3%), abdominal pain (3.7%), constipation (46.3%), excessive strain during defecation (33.3%), fecal incontinence (7.4%), tenesmus (20.4%), loose stool or diarrhea (3.7%), and difficulty in relaxing anal sphincter (11.1%). Two patients were scored at zero. Conclusions: Our findings confirm that gastrointestinal dysfunction occurs in early PD in relatively high frequency.
Citations
Citations to this article as recorded by
Movement disorders associated with diarrhoea Claudia Lazcano-Ocampo, Tobias Warnecke, Iro Boura, Daniele Urso, Valentina Leta, Karolina Poplawska-Domaszewicz, Lucia Batzu, Ece Bayram, Vanessa Raeder, Chin-Hsien Lin, Cristian Falup-Pecurariu, K. Ray Chaudhuri Journal of Neural Transmission.2026; 133(1): 15. CrossRef
Microbial Metabolism of Levodopa as an Adjunct Therapeutic Target in Parkinson’s Disease Jimmy B. Feix, Gang Cheng, Micael Hardy, Balaraman Kalyanaraman Antioxidants.2026; 15(1): 120. CrossRef
Rare Abdominal Manifestations in a Patient with Parkinson’s Disease after Deep Brain Stimulation of the Subthalamic Nucleus: A Case Report Hiroshi Koyama, Ryoma Morigaki, Kazuhisa Miyake, Taku Matsuda, Joji Fujikawa, Keisuke Shinohara, Yoshihiko Nishida, Yasushi Takagi Case Reports in Neurology.2026; 18(1): 128. CrossRef
Effects of daily walking exercise on constipation in patients with Parkinson’s disease Yi-Ping Wu, I-Chien Wu, Ming-Kuei Lu BMJ Open Sport & Exercise Medicine.2026; 12(1): e002696. CrossRef
Association of Gastrointestinal Symptoms With Severity and Progression of Cognitive Impairment in Parkinson’s Disease: A Systematic Review and Meta‐Analysis Kimberly Ho, Jeena Khan, Abraham Z. Cheloff, Ashish Malhotra, Aasma Shaukat Journal of Gastroenterology and Hepatology.2026; 41(6): 1659. CrossRef
Severe Colonic Dysmotility and Constipation Leading to Hydronephrosis in Advanced Parkinson’s Disease: A Case Report and Literature Review Giovannie Isaac-Coss, Swathi Kavuri, Jayalekshmi Jayakumar, Zoe Post, Atsushi Sakuraba Cureus.2025;[Epub] CrossRef
Muscle Dystonia Manifesting as Unilateral Rectus Abdominis Hypertrophy and Abdominal Pain in Parkinson’s Disease: A Case Report Chengjian Wu, Yanhui Meng, Ming Yang Journal of Movement Disorders.2025; 18(1): 108. CrossRef
Systemic exposure to rotenone toxicity induces gastro-inflammatory damage in mice: protective response of Zingiber officinale Roscoe extract Olusegun G. Adebayo, Emmanuel U. Modo, Blessing Ogechukwu Orji, Joseph Chimezie, Iheanyichukwu Wopara, Adebimpe V. Masanwoola, Ichipi-Ifukor Patrick Chukwuyenum, Benjamin Oritsemuelebi, Iria Kelly Esezobor Nutrire.2025;[Epub] CrossRef
Reported Symptoms in Prodromal and Early Motor Parkinson's Disease: A Scoping Review on the Patient Perspective Joseph Saade, Alice van Wyk, Glenn T. Stebbins, Tiago A. Mestre Movement Disorders Clinical Practice.2025; 12(6): 721. CrossRef
Gastrointestinal Manifestations in Parkinson's Disease Using a Validated Arabic Version of Gastrointestinal Dysfunction Scale: A Multicenter Study Ali Soliman Shalash, Marwa Yassien Badr, Yara Salah, Shimaa Elgamal, Shaimaa Ahmed Elaidy, Eman Abdel‐Mageed Elhamrawy, Hayam Abdel‐Tawab, Eman Hamid, Ehab Ahmed El‐Seidy, Noha Lotfy Dawood Movement Disorders Clinical Practice.2025; 12(7): 947. CrossRef
Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson’s Disease Jennifer R. Mammen, Jamie L. Adams, Rikki Mangrum, Yuge Xiao, William Barbosa, Mirinda Tyo, Christopher Redmond, Cheryl Carter, Kelly Cifelli, Robert Cifelli, Hope Maruzo, Jim Meeker, Gerry Shultz, Colbren Thomas, Claire Bale, Evan Davies, Catherine M. Ko npj Parkinson's Disease.2025;[Epub] CrossRef
Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson’s disease treatment Zimo Zang, Fang Yang, Liang Qu, Minghui Ge, Liang Tong, Lihui Xue, Xiuye Sun, Ying Hai Frontiers in Aging Neuroscience.2025;[Epub] CrossRef
Epidemiology of autonomic dysfunction in Parkinson's disease (Review) Jamir Rissardo, Ahmed Gadelmawla, Ibrahim Khalil, Ayah Abdulgadir, Karandeep Bhatti, Ana Fornari Caprara Medicine International.2025; 5(6): 1. CrossRef
Parkinson’s disease and the gut-brain connection: unveiling pathways, mechanisms and promising therapies Suhas Hajare, Yogesh A. Kulkarni Brain Research.2025; 1868: 149975. CrossRef
Parkinson’s disease beyond the brain: implications for treatments Setareh Malekian Naeini, Marc Danzell Lopez, Paul E. Fraser, Anurag Tandon Frontiers in Aging Neuroscience.2025;[Epub] CrossRef
Characteristics of pain symptoms in Parkinson’s disease Dung Thi Hoang, Frank Xing, Daniel Truong Clinical Parkinsonism & Related Disorders.2025; 13: 100404. CrossRef
Helicobacter pylori infection and α-synuclein pathology drive parallel neurodegenerative pathways in the substantia nigra Alejandro Soto-Avellaneda, Alice Prigent, Lindsay Meyerdirk, Noah Schautz, John Andrew Pospisilik, Lena Brundin, Michael X. Henderson Journal of Neuroinflammation.2025;[Epub] CrossRef
Neuroimmune Connectomes in the Gut and Their Implications in Parkinson’s Disease Beatriz Thomasi, Luisa Valdetaro, Brian Gulbransen, Ana Lúcia Tavares-Gomes Molecular Neurobiology.2024; 61(4): 2081. CrossRef
Effect of Lycium ruthenicum and Lycium barbarum intake on Parkinson based on microbiology and metabonomics: A randomized pilot trial Lingyu Wu, Liwen Chu, Hongdou Cao, Qi Tian, Hua Gao, Jinghong Huo, Qinghan Gao Food Bioscience.2024; 57: 103548. CrossRef
The missing piece of the puzzle – The key role of the dietitian in the management of Parkinson's disease Richelle Flanagan, Carley Rusch, Fiona E. Lithander, Indu Subramanian Parkinsonism & Related Disorders.2024; 121: 106021. CrossRef
Gastric-filling ultrasonography to evaluate gastric motility in patients with Parkinson's disease Xianwei Zou, Xiaqing Chen, Yanxia Wen, Xiaofeng Jing, Man Luo, Fengyue Xin, Yao Tang, Mengfei Hu, Jian Liu, Fan Xu Frontiers in Neurology.2024;[Epub] CrossRef
Water extract of ginseng alleviates parkinsonism in MPTP–induced Parkinson’s disease mice Ning Xu, Shuyang Xing, Jie Li, Bo Pang, Meichen Liu, Meiling Fan, Yu Zhao, Chun-Hua Wang PLOS ONE.2024; 19(9): e0296424. CrossRef
Neuronal threshold functions: Determining symptom onset in neurological disorders Luc Jordi, Ole Isacson Progress in Neurobiology.2024; 242: 102673. CrossRef
α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice Livia H. Morais, Joseph C. Boktor, Siamak MahmoudianDehkordi, Rima Kaddurah-Daouk, Sarkis K. Mazmanian npj Parkinson's Disease.2024;[Epub] CrossRef
Persistent intolerable abdominal pain in patients with Parkinson’s disease Hiroshi Kataoka, Kazuma Sugie Clinical Neurology and Neurosurgery.2023; 224: 107558. CrossRef
Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease Ji Hwan Kim, Jonghu Jeon, Young Lee, Seung Min Kim, Miju Cheon, Jun Yup Kim Clinical Nuclear Medicine.2023; 48(2): 143. CrossRef
The gut microbiota is an emerging target for improving brain health during ageing Marcus Boehme, Katherine Elizabeth Guzzetta, Caroline Wasén, Laura Michelle Cox Gut Microbiome.2023;[Epub] CrossRef
6-OHDA-Induced Changes in Colonic Segment Contractility in the Rat Model of Parkinson’s Disease Maria Del Pilar Murillo, Ebba Johansson, Victoria Bryntesson, Patrik Aronsson, Gunnar Tobin, Michael Winder, Thomas Carlsson, Stephen Fink Gastroenterology Research and Practice.2023; 2023: 1. CrossRef
Efficacy of acupuncture for the treatment of Parkinson’s disease-related constipation (PDC): A randomized controlled trial Ying-Jia Li, Ian-I Leong, Jing-Qi Fan, Ming-Yue Yan, Xin Liu, Wei-Jing Lu, Yuan-Yuan Chen, Wei-Qiang Tan, Yu-Ting Wang, Li-Xing Zhuang Frontiers in Neuroscience.2023;[Epub] CrossRef
Considerations for developing a targeted amino acid supplement for people with Parkinson’s disease that promotes health while accounting for pathophysiology and medication interference Jacob E Earp, Cristina Colon-Semenza, Dara L LoBuono Nutrition Reviews.2023; 81(8): 1063. CrossRef
Lactobacillus plantarum CCFM405 against Rotenone-Induced Parkinson’s Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis Chuanqi Chu, Leilei Yu, Yiwen Li, Hang Guo, Qixiao Zhai, Wei Chen, Fengwei Tian Nutrients.2023; 15(7): 1737. CrossRef
The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study Charlotte B. Stewart, David Ledingham, Victoria K. Foster, Kirstie N. Anderson, Sahana Sathyanarayana, Debra Galley, Nicola Pavese, Jacopo Pasquini Frontiers in Neurology.2023;[Epub] CrossRef
Association of dysphagia with altered brain glucose metabolism in Parkinson's disease Ji Yeon Oh, Eui Jin An, Young Lee, Seung Min Kim, Miju Cheon, Jun Yup Kim CNS Neuroscience & Therapeutics.2023; 29(9): 2498. CrossRef
Differential Findings on Anorectal Manometry in Patients with Parkinson's Disease and Defecatory Dysfunction Wendy Zhou, George Triadafilopoulos, Brooke Gurland, Houssam Halawi, Laren Becker, Patricia Garcia, Linda Nguyen, Mitchell Miglis, Srikanth Muppidi, Dong‐In Sinn, Safwan Jaradeh, Leila Neshatian Movement Disorders Clinical Practice.2023; 10(7): 1074. CrossRef
Abdominal pain in Parkinson’s disease A.A. Pilipovich, O.V. Vorobyova, S.A. Makarov Russian Journal of Pain.2023; 21(2): 12. CrossRef
Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the
Microbiota Become a Viable Therapeutic Strategy? Adejoke Y. Onaolapo, Folusho O. Ojo, Anthony T. Olofinnade, Joshua Falade, Ismail A. Lawal, Olakunle J. Onaolapo CNS & Neurological Disorders - Drug Targets.2023; 22(9): 1355. CrossRef
Constipation in Parkinson's Disease Eamonn M. M. Quigley Seminars in Neurology.2023; 43(04): 562. CrossRef
Autonomic symptoms in early-stage Parkinson’s patients and their relationship with cognition and disease parameters Esma KOBAK TUR, Eren GÖZKE Anatolian Current Medical Journal.2023; 5(4): 498. CrossRef
Lower gastrointestinal dysfunction in patients with Parkinson’s disease A.A. Pilipovich, O.V. Vorob’eva, S.A. Makarov, A.V. Kuchuk S.S. Korsakov Journal of Neurology and Psychiatry.2023; 123(12): 42. CrossRef
Related Effects of Methamphetamine on the Intestinal Barrier via Cytokines, and Potential Mechanisms by Which Methamphetamine May Occur on the Brain-Gut Axis Yuansen Li, Deshenyue Kong, Ke Bi, Huayou Luo Frontiers in Medicine.2022;[Epub] CrossRef
Alpha-synuclein and tau are abundantly expressed in the ENS of the human appendix and monkey cecum Alexandra D. Zinnen, Jonathan Vichich, Jeanette M. Metzger, Julia C. Gambardella, Viktoriya Bondarenko, Heather A. Simmons, Marina E. Emborg, Stephan N. Witt PLOS ONE.2022; 17(6): e0269190. CrossRef
Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches Roongroj Bhidayasiri, Warongporn Phuenpathom, Ai Huey Tan, Valentina Leta, Saisamorn Phumphid, K. Ray Chaudhuri, Pramod Kumar Pal Frontiers in Aging Neuroscience.2022;[Epub] CrossRef
Mechanisms of development of constipation in Parkinson’s disease and therapeutic approaches E.A. Katunina, N.N. Shipilova, D.A. Katunin Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2022; 122(8): 21. CrossRef
Intestinal Permeability, Dysbiosis, Inflammation and Enteric Glia Cells: The Intestinal Etiology of Parkinson’s Disease Huijia Yang, Song Li, Weidong Le Aging and disease.2022; 13(5): 1381. CrossRef
The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders Yasir Bashir, Asad U. Khan Frontiers in Neuroscience.2022;[Epub] CrossRef
Gender Differences and Impact of Autonomic Disturbance on Fatigue and Quality of Life in Parkinson's Disease Nahush R Bansal, Birinder S Paul, Gunchan Paul, Gagandeep Singh Neurology India.2022; 70(1): 203. CrossRef
Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease Bai-Hua Sun, Tao Wang, Nian-Ying Li, Qiong Wu, Jin Qiao World Journal of Gastrointestinal Pharmacology and Therapeutics.2021; 12(1): 21. CrossRef
Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case–Control Study in an Australian Cohort Jade E. Kenna, Megan C. Bakeberg, Anastazja M. Gorecki, Alfred Chin Yen Tay, Samantha Winter, Frank L. Mastaglia, Ryan S. Anderton Movement Disorders Clinical Practice.2021; 8(2): 245. CrossRef
Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned rat Cynthia Kwan, Imane Frouni, Dominique Bédard, Adjia Hamadjida, Philippe Huot Behavioural Pharmacology.2021; 32(1): 43. CrossRef
Deglutition Impairment during Dual Task in Parkinson Disease Is Associated with Cognitive Status Luciana Grolli Ardenghi, Alana Verza Signorini, Gerson Schulz Maahs, Fabio Selaimen, Konrado Massing Deutsch, Silvia Dornelles, Carlos Roberto de Mello Rieder International Archives of Otorhinolaryngology.2021; 25(01): e41. CrossRef
Spectrum of Non-Motor Symptoms in Parkinson's Disease Maithrayie Kumaresan, Safeera Khan Cureus.2021;[Epub] CrossRef
Onset of Skin, Gut, and Genitourinary Prodromal Parkinson's Disease: A Study of 1.5 Million Veterans Gregory D. Scott, Miranda M. Lim, Matthew G. Drake, Randy Woltjer, Joseph F. Quinn Movement Disorders.2021; 36(9): 2094. CrossRef
The Gastrointestinal Dysfunction Scale for Parkinson's Disease Marta Camacho, Julia C. Greenland, Caroline H. Williams‐Gray Movement Disorders.2021; 36(10): 2358. CrossRef
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, Anna Serefko, Marcin Włodarczyk, Anna Zielińska, Ewa Poleszak, Jakub Fichna, Piotr Wlaź Pharmacological Research.2021; 172: 105840. CrossRef
Neuro-Immunity and Gut Dysbiosis Drive Parkinson’s Disease-Induced Pain Katiane Roversi, Natalia Callai-Silva, Karine Roversi, May Griffith, Christos Boutopoulos, Rui Daniel Prediger, Sébastien Talbot Frontiers in Immunology.2021;[Epub] CrossRef
Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment Zhichun Chen, Guanglu Li, Jun Liu Neurobiology of Disease.2020; 134: 104700. CrossRef
Double‐Blind, Randomized, Placebo‐Controlled Trial of DA‐9701 in Parkinson's Disease: PASS‐GI Study Ji‐Hyun Choi, Jee‐Young Lee, Jin Whan Cho, Seong‐Beom Koh, Young Soon Yang, Dalla Yoo, Cheol‐Min Shin, Hee Tae Kim Movement Disorders.2020; 35(11): 1966. CrossRef
Parkinson disease and the gut: new insights into pathogenesis and clinical relevance R. Alberto Travagli, Kirsteen N. Browning, Michael Camilleri Nature Reviews Gastroenterology & Hepatology.2020; 17(11): 673. CrossRef
Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort Olivier Rascol, Laurence Negre-Pages, Philippe Damier, Arnaud Delval, Pascal Derkinderen, Alain Destée, Margherita Fabbri, Wassilios G. Meissner, Amine Rachdi, François Tison, Santiago Perez-Lloret Journal of Neural Transmission.2020; 127(12): 1607. CrossRef
Struktur und Efferenzen der Substantia nigra pars compacta beim idiopathischen Parkinson-Syndrom Peter Urban, Bjorn Falkenburger, Wolfgang H. Jost, Gerhard Ransmayr, Peter Riederer, Christian Winkler Fortschritte der Neurologie · Psychiatrie.2020; 88(09): 591. CrossRef
Parkinson’s disease: Are gut microbes involved? Yogesh Bhattarai, Purna C. Kashyap American Journal of Physiology-Gastrointestinal and Liver Physiology.2020; 319(5): G529. CrossRef
Does Bilateral Deep Brain Stimulation of the Subthalamic Nucleus Modify Ano-Rectal Motility in Parkinson’s Disease? Results of a Randomized Cross-Over Study Guillaume Gourcerol, David Maltete, Nathalie Chastan, Marie Laure Welter, Anne Marie Leroi, Stéphane Derrey Neuromodulation: Technology at the Neural Interface.2019; 22(4): 478. CrossRef
Probiotics for Parkinson’s Disease Parisa Gazerani International Journal of Molecular Sciences.2019; 20(17): 4121. CrossRef
Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats Amanda L. Persons, Brinda D. Bradaric, Hemraj B. Dodiya, Michael Ohene-Nyako, Christopher B. Forsyth, Ali Keshavarzian, Maliha Shaikh, T. Celeste Napier, Shilpa J. Buch PLOS ONE.2018; 13(1): e0190078. CrossRef
Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology Fredric P. Manfredsson, Kelvin C. Luk, Matthew J. Benskey, Aysegul Gezer, Joanna Garcia, Nathan C. Kuhn, Ivette M. Sandoval, Joseph R. Patterson, Alana O'Mara, Reid Yonkers, Jeffrey H. Kordower Neurobiology of Disease.2018; 112: 106. CrossRef
Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease Meng-Fei Sun, Yan-Qin Shen Ageing Research Reviews.2018; 45: 53. CrossRef
Parkinson’s Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects Chethan Ramprasad, Jane Yellowlees Douglas, Baharak Moshiree Current Treatment Options in Gastroenterology.2018; 16(4): 489. CrossRef
Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation Takashi Ogawa, Genko Oyama, Nobutaka Hattori BMJ Case Reports.2018; 2018: bcr-2017-223722. CrossRef
α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang Neurological Sciences.2017; 38(1): 171. CrossRef
The Threshold Theory for Parkinson's Disease Simone Engelender, Ole Isacson Trends in Neurosciences.2017; 40(1): 4. CrossRef
Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives Karoline Knudsen, Klaus Krogh, Karen Østergaard, Per Borghammer Movement Disorders.2017; 32(1): 94. CrossRef
Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying? Maria Nord, Anita Kullman, Ulf Hannestad, Nil Dizdar Advances in Parkinson's Disease.2017; 06(01): 1. CrossRef
Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo Journal of Movement Disorders.2017; 10(1): 29. CrossRef
Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis C.-H. Chen, C.-L. Lin, C.-H. Kao Osteoporosis International.2016; 27(6): 2117. CrossRef
Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies Syed Ali, Ning Yin, Arkam Rehman, Verline Justilien Medical Sciences.2016; 4(1): 1. CrossRef
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models C. Pellegrini, R. Colucci, L. Antonioli, E. Barocelli, V. Ballabeni, N. Bernardini, C. Blandizzi, W. J. de Jonge, M. Fornai Neurogastroenterology & Motility.2016; 28(12): 1781. CrossRef
Gut dysfunction in Parkinson's disease Adreesh Mukherjee, Atanu Biswas, Shyamal Kumar Das World Journal of Gastroenterology.2016; 22(25): 5742. CrossRef
Inflammation is genetically implicated in Parkinson’s disease N. Dzamko, C.L Geczy, G.M Halliday Neuroscience.2015; 302: 89. CrossRef
Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-OHDA-induced Parkinson’s disease rats Xiaoli Zhang, Yun Li, Chenzhe Liu, Ruifang Fan, Ping Wang, Lifei Zheng, Feng Hong, Xiaoyan Feng, Yue Zhang, Lisheng Li, Jinxia Zhu Translational Research.2015;[Epub] CrossRef
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease Jose L Barboza, Michael S Okun, Baharak Moshiree Expert Opinion on Pharmacotherapy.2015; 16(16): 2449. CrossRef
Gastrointestinal Dysfunctions in Parkinson’s Disease Joong-Seok Kim, Hey Young Sung Journal of the Korean Neurological Association.2015; 33(4): 247. CrossRef